Wednesday, August 20, 2008

Inhaled DHE Offers Advantages Over IV DHE


New to Somebody Heal Me? Subscribe to the Somebody Heal Me feed:
Subscribe in a reader or subscribe by e-mail. Follow me on Twitter @somebodyhealme.

According to research presented at the American Headache Society annual meeting, an orally inhaled version of DHE (dihydroergotamine) offers migraine treatment comparable to IV DHE with fewer side effects.

MAP Pharmaceuticals Initiates Phase 3 Clinical Trial In Patients With Migraine

The product is self-administered via a Tempo Inhaler (shown at left), a MAP Pharmaceuticals' product.

The inhaled DHE was well tolerated among study subjects. It decreased migraine-associated nausea and sensitivity to light and sound.

Right after I wrote this, I saw an article on My Migraine Connection about the same topic. You'll want to read it for more in depth information about this product.

MAP0004 Shows Promise for Aborting Migraines

Technorati Tags: , , , , , , , , ,


Subscribe to the Somebody Heal Me feed: Subscribe in a reader or subscribe by e-mail.

Photo Sharing and Video Hosting at Photobucket Content by Diana E. Lee.